- Home
- PODD vs SYF Comparison
PODD vs SYF Comparison
Compare PODD & SYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODD
- SYF
- Stock Information
- Founded
- PODD 2000
- SYF 1932
- Country
- PODD United States
- SYF United States
- Employees
- PODD N/A
- SYF N/A
- Industry
- PODD Medical/Dental Instruments
- SYF Finance: Consumer Services
- Sector
- PODD Health Care
- SYF Finance
- Exchange
- PODD Nasdaq
- SYF Nasdaq
- Market Cap
- PODD 21.5B
- SYF 20.3B
- IPO Year
- PODD 2007
- SYF N/A
- Fundamental
- Price
- PODD $299.96
- SYF $68.20
- Analyst Decision
- PODD Strong Buy
- SYF Buy
- Analyst Count
- PODD 19
- SYF 20
- Target Price
- PODD $320.11
- SYF $63.42
- AVG Volume (30 Days)
- PODD 858.4K
- SYF 3.4M
- Earning Date
- PODD 08-07-2025
- SYF 07-22-2025
- Dividend Yield
- PODD N/A
- SYF 1.75%
- EPS Growth
- PODD 67.46
- SYF 4.77
- EPS
- PODD 5.55
- SYF 7.27
- Revenue
- PODD $2,198,900,000.00
- SYF $8,705,000,000.00
- Revenue This Year
- PODD $24.49
- SYF $99.94
- Revenue Next Year
- PODD $17.45
- SYF $5.22
- P/E Ratio
- PODD $54.05
- SYF $9.41
- Revenue Growth
- PODD 23.48
- SYF 0.44
- 52 Week Low
- PODD $173.00
- SYF $40.55
- 52 Week High
- PODD $329.33
- SYF $70.93
- Technical
- Relative Strength Index (RSI)
- PODD 53.70
- SYF 76.00
- Support Level
- PODD $305.07
- SYF $61.48
- Resistance Level
- PODD $316.00
- SYF $61.65
- Average True Range (ATR)
- PODD 6.33
- SYF 1.29
- MACD
- PODD -0.34
- SYF 0.49
- Stochastic Oscillator
- PODD 69.72
- SYF 94.90
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.
About SYF Synchrony Financial
Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).